Estradiol and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Estradiol (estradiol) and Mobic (meloxicam). Common drug interactions include obsessive-compulsive disorder among females and ankle fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Estradiol and Mobic. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Estradiol?

Estradiol has active ingredients of estradiol. It is often used in menopause. eHealthMe is studying from 18,986 Estradiol users. Check the latest studies of Estradiol.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.



On Jul, 17, 2026

91 people who take Estradiol and Mobic together, and have interactions are studied.

Estradiol and Mobic drug interactions.

What are the common drug interactions of Estradiol and Mobic, by gender? *:

female:

  1. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  2. Depression
  3. Diarrhoea
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Osteoporosis (bones weak and more likely to break)
  8. Cellulitis (infection under the skin)
  9. Chronic kidney disease
  10. Joint effusion (presence of extra fluid in joint covering)

male:

  1. Ankle fracture
  2. Cellulitis (infection under the skin)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Increased upper airway secretion
  5. Joint dislocation (a joint position is changed from normal position)
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Oedema peripheral (superficial swelling)
  8. Oropharyngeal pain
  9. Peripheral swelling
  10. Red blood cell count decreased

What are the common drug interactions of Estradiol and Mobic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Chest discomfort
  4. Diarrhoea
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Pain in extremity
  9. Throat tightness
  10. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))

50-59:

  1. Drug ineffective
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Increased upper airway secretion
  4. Local swelling (swelling at the site of some application of substance or injury)
  5. Oedema peripheral (superficial swelling)
  6. Oropharyngeal pain
  7. Red blood cell count decreased
  8. White blood cell count decreased
  9. Abdominal pain upper
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Headache (pain in head)
  2. Depression
  3. Hypertension (high blood pressure)
  4. Injection site erythema (redness at injection site)
  5. Injection site pain
  6. Insomnia (sleeplessness)
  7. Joint dislocation (a joint position is changed from normal position)
  8. Joint effusion (presence of extra fluid in joint covering)
  9. Lower limb fracture
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 19.78%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 15.38%
  3. High Blood Cholesterol: 12 people, 13.19%
  4. High Blood Pressure: 11 people, 12.09%
  5. Pain: 10 people, 10.99%
  6. Sleep Disorder: 9 people, 9.89%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 9.89%
  8. Depression: 8 people, 8.79%
  9. Hypersensitivity: 8 people, 8.79%
  10. Thyroid Diseases: 7 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Estradiol and Mobic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Estradiol and Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Estradiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Estradiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on estradiol and meloxicam (the active ingredients of Estradiol and Mobic, respectively), and Estradiol and Mobic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: